Medicare GLP-1 Bridge
Found Health to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients
For adults 65–75 on Medicare Part D, Found prescribes branded Zepbound, Wegovy or Foundayo through the CMS Medicare GLP-1 Bridge at a $50 monthly copay — and files the prior authorization the program hinges on.
- Branded Zepbound®, Wegovy® or Foundayo™ — not compounded
- $50 per 30-day supply through the federal Bridge
- Ages 65–75 with Medicare Part D drug coverage
- Prior authorization filed and tracked for you
$50/mo medication copay (from $99/mo all-in)
Free 3-minute check · Plan verified before you pay · Found membership from $49/mo billed annually
By Charly P. · Not medically reviewed
Published August 2026 · Pricing last checked August 2026
- Branded FDA-approved GLP-1s
- $50/mo copay via the Bridge
- Ages 65–75, Part D
- Paperwork done for you
For as long as GLP-1s have existed, the people most likely to benefit from them have been the people Medicare could not cover. Part D is barred by statute from paying for drugs used for weight reduction, so a 68-year-old with a BMI of 36 and a prescription in hand was quoted the full cash price and told to take it up with their insurer. That changed on July 1, 2026, when CMS opened the Medicare GLP-1 Bridge, a nationwide demonstration that puts branded GLP-1s in front of eligible Part D beneficiaries for a flat $50 per 30-day supply. Found — a telehealth weight-care platform with more than 300,000 members — is now offering that route to Medicare Part D patients aged 65 to 75, prescribing Zepbound®, Wegovy® or Foundayo™ and filing the prior authorization that the program hinges on.
What Found Is Offering Medicare Part D Patients
| Program | Found Medicare GLP-1 Bridge route |
|---|---|
| Who it serves | Adults aged 65–75 with active Medicare Part D drug coverage |
| Medications | Zepbound® KwikPen®, Wegovy® (injection or tablet), Foundayo™ (orforglipron) |
| Medication cost | $50 per 30-day supply — the federal Bridge copay |
| Found membership | From $49/month when billed annually |
| Total starting price | From $99/month on the 12-month plan |
| Paperwork handled | Plan verification plus the Bridge prior authorization, filed and tracked |
| Eligibility check | Free, about 3 minutes, no commitment |
| Clinician review | Board-certified clinicians, typically 1–2 days |
| Ongoing care | Monthly check-ins, in-app side-effect support, messaging with your care team |
| Fulfillment | Licensed pharmacy, shipped to your door |
| Found’s comparison figure | $198/month, which Found shows struck through against the $50 copay |
| Company scale | 300,000+ members, 1.4M lbs lost, 4.89 average rating |
Every Medication Covered Through the Bridge
Found lists three medications under its Medicare route — Zepbound®, Wegovy® and Foundayo™ — which are exactly the three CMS made eligible. Formulation matters more than most people expect, because the demonstration covers some presentations of a drug and not others.
| Medication | Formulations covered | What it is |
|---|---|---|
| Wegovy® | All formulations — weekly injection and oral tablet | Semaglutide, from Novo Nordisk |
| Zepbound® | KwikPen® only — single-dose pens and vials are excluded | Tirzepatide, from Eli Lilly — the most-prescribed obesity medication in the U.S. |
| Foundayo™ | All formulations — once-daily oral tablet | Orforglipron, from Eli Lilly — FDA-approved April 2026, no food or timing restrictions |
Two practical notes. Pen needles are not covered by the demonstration, so budget for those separately. And if you hold an older prescription written for a Zepbound vial or single-dose pen, it needs rewriting for the KwikPen before a Bridge claim will process — a covered drug in an uncovered presentation is still a rejected claim at the counter. Both oral options mean an injection is no longer the only route; we compare the pills in our Foundayo pill provider guide.
Zepbound, Wegovy or Foundayo — $50/month if you qualify
Check Coverage for Your Medication →Free eligibility check · About 3 minutes · No commitment
Why This Is a Bigger Deal Than a Discount
The Bridge is not a coupon and not a manufacturer savings card. It is a federal demonstration that operates outside the Part D benefit entirely: your plan sponsor carries no risk, never sees the claim, and does not have to opt in. A single CMS central processor handles prior authorization, claims and pharmacy payment, with manufacturers accepting a net price of roughly $245 per 30-day supply. You pay $50 of it.
Roughly 3.8 million Medicare beneficiaries are estimated to meet the criteria, and the program is the first time Medicare has broadly paid for a GLP-1 prescribed for weight itself rather than for diabetes or another approved non-obesity indication. Full program mechanics are published by CMS, and eligible beneficiaries can also call 1-800-MEDICARE.
What Found sells into that gap is not the discount. Anyone eligible can get the $50 copay through any willing prescriber. What Found sells is the part that actually stops people: getting a clinician to document the right BMI tier and qualifying condition, write the prescription for a covered formulation, and file a sworn prior authorization with a processor most practices had never heard of eight weeks ago.
The paperwork is the barrier, not the price
Start Your Free Eligibility Check →Found verifies your Part D plan before you are charged
Who Qualifies — and Who Does Not
Two sets of criteria stack. Found’s own program is built for the 65–75 band with active Part D coverage. On top of that sit the federal Bridge requirements, which are narrower than most coverage headlines have suggested.
The three qualifying tiers
| Tier | BMI | Required condition |
|---|---|---|
| Tier 1 | 35 or higher | None — BMI alone qualifies, with lifestyle modification |
| Tier 2 | 30 or higher | Heart failure, uncontrolled hypertension, or chronic kidney disease stage 3a or worse |
| Tier 3 | 27 or higher | Prediabetes, prior heart attack or stroke, or symptomatic peripheral artery disease |
The diagnoses that push you out
- ✕Type 2 diabetes — routes to standard Part D coverage instead of the Bridge.
- ✕Moderate-to-severe obstructive sleep apnea — Zepbound is FDA-approved for this and goes through Part D.
- ✕MASH (metabolic dysfunction-associated steatohepatitis) — also routes through Part D.
- ✕No Part D drug coverage at all — Original Medicare alone does not reach the Bridge.
Medicare’s own weight-loss drug coverage page is explicit on one further exclusion: you are not eligible for the Bridge if you already get a GLP-1 covered through your Part D plan. Being pushed out is frequently the better financial outcome, and it is worth saying plainly: Part D spending counts toward your annual out-of-pocket cap, and Bridge spending does not. A beneficiary with a sleep apnea diagnosis on file may well pay less across a full year through their plan than through the demonstration. We work through that comparison in our Medicare GLP-1 Bridge program guide.
Free eligibility check · No card required
Why Start With Found? The Medication Is One Part
Found frames its Medicare offer around three things beyond the prescription itself, and they are the reasons to pay a membership on top of a copay anyone eligible can reach.
- 1.We handle the paperwork
Prior authorization, filed and tracked by Found’s team — start to finish.
- 2.A care team, not just a prescription
Board-certified clinicians, regular check-ins, and side-effect support in the app.
- 3.Care built for ages 65–75
Simple at-home visits and a plan made for starting a GLP-1 later in life.
The third one is positioning rather than a separately published protocol, but it points at something real: dose titration, muscle preservation and drug interactions all deserve more care at 70 than at 35. Found publishes its clinicians by name with individual patient ratings — Dr. Jennifer Wetherington (4.91), Dr. Molly Middleton (4.93), Kai Lehardi NP (4.87) and Gem Escamilla NP (4.85) — which is more transparency than most telehealth platforms offer.
How Found's Medicare Route Works, Step by Step
Found describes four steps, all of them online, from eligibility check to medication at your door.
- 1.Take a 3-minute health assessment
Questions built by the same licensed clinicians who review your case, and it doubles as the free eligibility check for the Medicare route. No commitment and no payment at this stage.
- 2.A board-certified clinician reviews your profile (1–2 days)
A real clinician, not an algorithm, evaluates whether GLP-1 medication is medically appropriate. If approved, your prescription is written.
- 3.Your medication ships directly to you
Prepared by a licensed pharmacy and shipped to your door. Found states that its team verifies your plan and files the paperwork before you pay anything.
- 4.Ongoing care that adapts with you
Monthly clinician check-ins keep your dose optimized, refills are handled, and you can message your care team between visits.
Step one takes three minutes and costs nothing
Begin Your Free Assessment →Found verifies your Part D plan before you pay anything
What It Costs — Honestly
What you'll pay
| Medication copay | $50/mo |
|---|---|
| Found membership | Starting at $49/mo |
| Total starting at | $99/mo — best price on the 12-month plan |
| Included | Insurance paperwork handled by Found |
| Included | Ongoing clinician support |
| Included | Prescription management |
| Route | Monthly cost | What you get |
|---|---|---|
| Found Medicare route | From $99 all-in | $50 Bridge medication copay plus membership from $49/mo billed annually |
| Bridge through your own doctor | $50 | Same medication, same copay — you coordinate the prescription and prior authorization yourself |
| Branded GLP-1 without coverage | Found shows $198 as its comparison figure | Varies widely by pharmacy, manufacturer program and formulation — check your own quote |
| Compounded GLP-1 cash-pay | Under $100 | Not FDA-approved finished products; no insurance and no eligibility gate |
The comparison worth sitting with is the second row. The $50 copay is a federal entitlement for anyone eligible, not something Found grants you — the membership buys the clinical program and the administrative work, not access to the price. If your own physician files Bridge requests routinely and you are comfortable chasing the pharmacy and the processor, you can reach the same $50 without a membership. If they do not, or you would rather not, the roughly $49 a month is what that convenience costs. Read the refund and cancellation terms before enrolling. Our full Found Medicare GLP-1 Bridge review goes through the membership terms in detail, and our comparison of Medicare bridge programs shows the alternatives.
Strengths and Trade-offs
Pros
- Branded, FDA-approved medication — Zepbound, Wegovy and Foundayo, not a compounded substitute.
- $50 medication copay, which Found shows against a $198/month comparison figure for the same medication.
- The prior authorization — the actual bottleneck — is filed and tracked for you.
- Free plan verification and eligibility check before any payment.
- A program designed around starting a GLP-1 later in life, with monthly clinician check-ins.
- Foundayo and the Wegovy tablet mean an injection is no longer the only covered option.
Cons
- Found’s Medicare route is scoped to ages 65–75; younger Part D beneficiaries qualify federally but need another prescriber.
- The $50 copay does not count toward your Part D deductible or the $2,100 out-of-pocket cap, and Extra Help does not reduce it.
- Membership is an additional cost on top of the copay, and the cheapest rate assumes a 12-month commitment.
- The Bridge itself expires December 31, 2027, and its successor programme is unsettled.
- Only the Zepbound KwikPen is covered — single-dose pens and vials are not.
3 minutes · No commitment
If You Do Not Qualify
Falling outside the criteria is common and it is not the end of the road. The cash-pay telehealth market has no eligibility gate, no prior authorization and no BMI tier: compounded semaglutide and tirzepatide programs start under $100 a month, and branded Wegovy through a telehealth partner typically runs $149 to $299 depending on formulation and plan length. Our ranking of the best weight loss treatments for 2026 covers that field.
Frequently Asked Questions
Recommended Providers
Our editorial team’s top picks for this category.
Editorial Verdict
Our Editorial Take
Found is not creating the $50 price — CMS did that, and any eligible beneficiary can reach it through any willing prescriber. What Found is doing is removing the friction that has kept the Bridge theoretical for a lot of people since July 1: a clinician who knows the BMI tiers, a prescription written for a covered formulation, and a prior authorization filed with the right processor the first time. For an adult aged 65 to 75 on Part D who has already been quoted the cash price, from $99 a month all-in for branded, FDA-approved medication is a straightforward trade.
The honest caveats are the eligibility tiers, the fact that Bridge spending does not touch your out-of-pocket cap, and an 18-month clock. The free three-minute check answers the first one without costing you anything, which is the right place to start.
Branded Zepbound/Wegovy/Foundayo at a $50/mo copay
Check Your $50 Medicare GLP-1 Eligibility →Free · 3 minutes · Plan verified before you pay anything
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.